Physician

Jeffery C Weeks, MD

According to 2025 Medicare claims, Jeffery Weeks, MD (NPI: 1538100011) practices dermatology in the Tuscaloosa, AL market, with the plurality of this provider's patient population coming from Tuscaloosa, AL. This provider's primary affiliated billing organization is ALABAMA DERMATOLOGY ASSOCIATES, PC (NPI: 1033128897; TIN: 63-0776876) and primary practice location at 35473-5204.

Weeks' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,322 traditional Medicare patients, billed 9,375 HCPCS/CPT codes, and received $376,796 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 3,488 prescription claims across 936 beneficiaries totaling $4,784,173 in drug costs, led by Skyrizi Pen (Risankizumab-Rzaa). Open Payments data shows 163 records totaling $3,223. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $391,998 and ending at $376,796. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $390,093 to $4,784,173. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,603	11,571	$391,998
2016	1,739	13,018	$404,892
2017	1,369	10,359	$315,186
2018	1,271	10,559	$300,369
2019	1,230	14,924	$306,628
2020	1,050	7,335	$230,977
2021	1,042	7,737	$267,402
2022	1,096	8,019	$297,537
2023	1,183	9,096	$525,174
2024	1,322	9,375	$376,796

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	646	1,979	$390,093
2016	603	1,907	$482,699
2017	636	2,020	$528,319
2018	682	2,252	$814,220
2019	723	2,444	$1,208,047
2020	692	2,482	$1,796,629
2021	757	2,732	$2,172,364
2022	803	3,094	$2,856,774
2023	831	3,141	$4,180,815
2024	936	3,488	$4,784,173

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17110	Destruction of skin growth, 1-14 growths	584	750	$72
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	1,019	1,501	$57
11102	Biopsy of related skin growth, first growth	314	355	$54
17000	Destruction of precancer skin growth, 1 growth	804	1,097	$33
17003	Destruction of precancer skin growth, 2-14 growths	642	4,326	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Skyrizi Pen	Risankizumab-Rzaa	71	5,460	$1,445,265
Dupixent Pen	Dupilumab	145	4,004	$552,313
Cosentyx Sensoready (2 Pens)	Secukinumab	67	1,876	$512,356
Stelara	Ustekinumab	25	2,100	$404,775
Tremfya	Guselkumab	22	1,232	$304,331

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	163	$3,223	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jeffery C. Weeks, MD?

Tedicare shows public-source Medicare data for Jeffery C. Weeks, MD (NPI 1538100011), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jeffery C. Weeks, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jeffery C. Weeks, MD?

Jeffery C. Weeks, MD is linked to ALABAMA DERMATOLOGY ASSOCIATES, PC (billing NPI 1033128897) in the available physician profile data.

Does Jeffery C. Weeks, MD have Open Payments data?

Jeffery C. Weeks, MD has 163 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.